Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 119272
Published online Jun 27, 2026. doi: 10.4240/wjgs.119272
Published online Jun 27, 2026. doi: 10.4240/wjgs.119272
Figure 1 Schematic description of the study design.
ATG: Adjuvant therapy group; PSM: Propensity score matching; SG: Surgery-alone group.
- Citation: Li QS, Hu AY, Chen SJ, Yu GJ, Fan Y, Chen YG, Tian S, Peng CJ, Han M. Efficacy and safety of adjuvant targeted immunotherapy for hepatocellular carcinoma with high recurrence risks after hepatectomy. World J Gastrointest Surg 2026; 18(6): 119272
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/119272.htm
- DOI: https://dx.doi.org/10.4240/wjgs.119272